KR860001270B1 - 1-페닐-2(1h, 3h)-인돌온유도체의 제조방법 - Google Patents

1-페닐-2(1h, 3h)-인돌온유도체의 제조방법 Download PDF

Info

Publication number
KR860001270B1
KR860001270B1 KR1019830004396A KR830004396A KR860001270B1 KR 860001270 B1 KR860001270 B1 KR 860001270B1 KR 1019830004396 A KR1019830004396 A KR 1019830004396A KR 830004396 A KR830004396 A KR 830004396A KR 860001270 B1 KR860001270 B1 KR 860001270B1
Authority
KR
South Korea
Prior art keywords
indoleone
dimethylaminomethylene
chloro
indolone
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019830004396A
Other languages
English (en)
Korean (ko)
Other versions
KR840006239A (ko
Inventor
랄프 호워드 해리
세이지즈 레인하드
Original Assignee
화이자 인코포레이티드
윌리암 데이비스 훈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 인코포레이티드, 윌리암 데이비스 훈 filed Critical 화이자 인코포레이티드
Publication of KR840006239A publication Critical patent/KR840006239A/ko
Priority to KR1019860005907A priority Critical patent/KR860001272B1/ko
Priority to KR1019860005906A priority patent/KR860001271B1/ko
Priority to KR1019860005908A priority patent/KR860001297B1/ko
Application granted granted Critical
Publication of KR860001270B1 publication Critical patent/KR860001270B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019830004396A 1982-09-20 1983-09-19 1-페닐-2(1h, 3h)-인돌온유도체의 제조방법 Expired KR860001270B1 (ko)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1019860005907A KR860001272B1 (ko) 1982-09-20 1986-07-19 1-페닐-2(1h, 3h)-인돌온 유도체의 제조방법
KR1019860005906A KR860001271B1 (ko) 1982-09-20 1986-07-19 1-페닐 -2(1h, 3h)-인돌온유도체의 제조방법
KR1019860005908A KR860001297B1 (ko) 1982-09-20 1986-07-19 1-페닐-2(1h, 3h)-인돌온 유도체의 제조방법

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US420544 1982-09-20
US06/420,544 US4476307A (en) 1982-09-20 1982-09-20 Heteroylidene indolone compounds

Related Child Applications (3)

Application Number Title Priority Date Filing Date
KR1019860005908A Division KR860001297B1 (ko) 1982-09-20 1986-07-19 1-페닐-2(1h, 3h)-인돌온 유도체의 제조방법
KR1019860005907A Division KR860001272B1 (ko) 1982-09-20 1986-07-19 1-페닐-2(1h, 3h)-인돌온 유도체의 제조방법
KR1019860005906A Division KR860001271B1 (ko) 1982-09-20 1986-07-19 1-페닐 -2(1h, 3h)-인돌온유도체의 제조방법

Publications (2)

Publication Number Publication Date
KR840006239A KR840006239A (ko) 1984-11-22
KR860001270B1 true KR860001270B1 (ko) 1986-09-04

Family

ID=23666904

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830004396A Expired KR860001270B1 (ko) 1982-09-20 1983-09-19 1-페닐-2(1h, 3h)-인돌온유도체의 제조방법

Country Status (24)

Country Link
US (1) US4476307A (enExample)
EP (1) EP0104860B1 (enExample)
JP (1) JPS5976058A (enExample)
KR (1) KR860001270B1 (enExample)
AT (1) ATE25972T1 (enExample)
AU (1) AU543115B2 (enExample)
CA (1) CA1194871A (enExample)
DD (1) DD213211A5 (enExample)
DE (1) DE3370325D1 (enExample)
DK (1) DK157010C (enExample)
ES (3) ES8503328A1 (enExample)
FI (1) FI77446C (enExample)
GR (1) GR79732B (enExample)
HU (1) HU189747B (enExample)
IE (1) IE55923B1 (enExample)
IL (1) IL69758A (enExample)
NO (1) NO161557C (enExample)
NZ (1) NZ205638A (enExample)
PH (1) PH18297A (enExample)
PL (3) PL141370B1 (enExample)
PT (1) PT77360B (enExample)
SU (1) SU1272983A3 (enExample)
YU (4) YU189283A (enExample)
ZA (1) ZA836933B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879391A (en) * 1982-09-20 1989-11-07 Pfizer Inc. 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
WO1990008146A1 (en) * 1989-01-10 1990-07-26 Pfizer Inc. Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides
US5078756A (en) * 1990-01-12 1992-01-07 Major Thomas O Apparatus and method for purification and recovery of refrigerant
US5158969A (en) * 1991-08-21 1992-10-27 Neurosearch A/S Indole derivatives as potassium channel blockers
US5760250A (en) * 1991-11-05 1998-06-02 Zeneca Limited Process for the preparation of 3-(α-methoxy)methylenebenzofuranones and intermediates therefor
DE19949209A1 (de) * 1999-10-13 2001-04-19 Boehringer Ingelheim Pharma In 5-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US6765012B2 (en) * 2001-09-27 2004-07-20 Allergan, Inc. 3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
IL163992A0 (en) * 2002-03-27 2005-12-18 Lundbeck & Co As H Method for manufacture of sertindole
FR2847811B1 (fr) * 2002-11-29 2005-01-07 Oreal Composition filtrante contenant au moins un derive du dibenzoylmethane et au moins un derive de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one;procede de photostabilisation
FR2847813A1 (fr) * 2002-11-29 2004-06-04 Oreal Compositions cosmetiques photoprotectrices contenant des derives de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one et utilisations
PT1928454E (pt) 2005-05-10 2014-12-04 Intermune Inc Derivativos da piridona para modulação do sistema de proteína quinase ativada pelo stress
US8304413B2 (en) 2008-06-03 2012-11-06 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
KR20130136591A (ko) 2008-12-19 2013-12-12 닛뽕소다 가부시키가이샤 １-헤테로디엔 유도체 및 유해 생물 방제제
KR101376443B1 (ko) 2009-11-12 2014-03-19 닛뽕소다 가부시키가이샤 1-헤테로디엔 유도체 및 유해 생물 방제제
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
KR102373700B1 (ko) 2014-04-02 2022-03-11 인터뮨, 인크. 항섬유성 피리디논

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3506683A (en) * 1963-10-07 1970-04-14 Upjohn Co 3-(2-pyrrolidinylidene)-3h-indoles
GB1237008A (en) * 1968-12-18 1971-06-30 Pfizer Ltd Novel indoline derivatives
US3723457A (en) * 1969-09-30 1973-03-27 Eisai Co Ltd Indoline-2-one derivatives and preparation thereof
GB1374414A (en) * 1972-06-12 1974-11-20 Sterling Drug Inc 1-acyl-3-amino-alkyl-indoles and their preparation
DE2557342A1 (de) * 1975-12-19 1977-06-30 Hoechst Ag Basisch substituierte indolderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DK425383D0 (da) 1983-09-19
JPS5976058A (ja) 1984-04-28
FI77446C (fi) 1989-03-10
YU169186A (en) 1987-10-31
IE55923B1 (en) 1991-02-27
DK157010B (da) 1989-10-30
ES8505950A1 (es) 1985-06-01
ES8505951A1 (es) 1985-06-01
PL250768A1 (en) 1985-07-02
YU169386A (en) 1987-10-31
AU1925283A (en) 1984-03-29
SU1272983A3 (ru) 1986-11-23
AU543115B2 (en) 1985-04-04
HU189747B (en) 1986-07-28
ES525737A0 (es) 1985-02-16
PL141609B1 (en) 1987-08-31
FI833335A7 (fi) 1984-03-21
PT77360A (en) 1983-10-01
ES8503328A1 (es) 1985-02-16
NO833367L (no) 1984-03-21
DK157010C (da) 1990-03-26
FI833335A0 (fi) 1983-09-19
JPS6241711B2 (enExample) 1987-09-04
CA1194871A (en) 1985-10-08
PT77360B (en) 1986-05-19
PL141876B1 (en) 1987-09-30
YU189283A (en) 1987-10-31
FI77446B (fi) 1988-11-30
US4476307A (en) 1984-10-09
IL69758A (en) 1986-12-31
PL250769A1 (en) 1985-07-02
NZ205638A (en) 1986-12-05
ZA836933B (en) 1985-05-29
IL69758A0 (en) 1983-12-30
NO161557B (no) 1989-05-22
PH18297A (en) 1985-05-24
KR840006239A (ko) 1984-11-22
NO161557C (no) 1989-08-30
EP0104860B1 (en) 1987-03-18
EP0104860A1 (en) 1984-04-04
ES531907A0 (es) 1985-06-01
DK425383A (da) 1984-05-03
IE832193L (en) 1984-03-20
ATE25972T1 (de) 1987-04-15
PL243826A1 (en) 1985-04-24
DD213211A5 (de) 1984-09-05
GR79732B (enExample) 1984-10-31
PL141370B1 (en) 1987-07-31
ES531908A0 (es) 1985-06-01
YU169286A (en) 1987-10-31
DE3370325D1 (en) 1987-04-23

Similar Documents

Publication Publication Date Title
KR860001270B1 (ko) 1-페닐-2(1h, 3h)-인돌온유도체의 제조방법
KR100647726B1 (ko) 피리다진-3-온 유도체 및 이를 함유하는 의약
US6235752B1 (en) Isoquinolinamine and phthalazinamine derivatives which interact with CRF receptors
CA2655913A1 (en) Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility
JPWO2000050408A1 (ja) ピリダジン−３−オン誘導体及びこれを含有する医薬
KR860001271B1 (ko) 1-페닐 -2(1h, 3h)-인돌온유도체의 제조방법
KR860001272B1 (ko) 1-페닐-2(1h, 3h)-인돌온 유도체의 제조방법
KR860001297B1 (ko) 1-페닐-2(1h, 3h)-인돌온 유도체의 제조방법
AU2002331179B2 (en) Aminopyrrole compounds as antiinflammatory agents
HU176980B (hu) Sposob poluchenija 1,3,5-triazin-2,6-dionov
US4879391A (en) 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents
US4977178A (en) Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents
US4861880A (en) 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents
JPS60158170A (ja) エテニルフェノールインドール誘導体及びそれらの塩、これらの製造方法並びにこれらを含有する薬剤
JP2002526535A (ja) プロスタグランジン受容体リガンドとしてのビフェニレンラクタム
AU2002331179A1 (en) Aminopyrrole compounds as antiinflammatory agents
JP3694774B2 (ja) フェニルカルボン酸誘導体
JPH0128019B2 (enExample)
IL179029A (en) Piperazine derivatives of dialkyl oxindoles, pharmaceutical compositions comprising the same, process for their manufacture and uses thereof
Parmar et al. Novel thiophene derivatives as Anti-inflammatory agents
FR2669928A1 (fr) Nouveaux derives de pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
Van Heyningen Synthesis of Some Quinoline and Pyridine Derivatives

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 19900723

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19910905

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19910905

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000